All In Biotech

Drug Trial Radar · NCT06734208

A Study to Evaluate the Pharmacokinetics of Divarasib in Healthy Participants and Participants With Impaired Hepatic Function

A Phase 1, Open-Label, Single-Dose, Parallel-Cohort Study to Evaluate the Pharmacokinetics of Divarasib in Subjects With Impaired Hepatic Function

Last checked: Nov 19, 2026Latest source record: Dec 4, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

31

Actual

Start

Jan 31, 2025

Primary completion

Nov 27, 2025

Study completion Nov 27, 2025

Sponsor

Lead sponsor
Genentech, Inc.Roche (Genentech) (RHHBY)
Sponsor type
Industry
First posted
Dec 16, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is a phase 1, open-label, single-dose, parallel-cohort study to determine the pharmacokinetics (PK) of divarasib in healthy participants and participants with varying degrees of hepatic impairment, as defined by Child-Pugh classification.

Conditions

  • Hepatic Impairment

Interventions

  • DivarasibDrug

    Divarasib will be administered as a single oral dose as specified for the respective cohort.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Plasma Concentration of DivarasibTime frame: Day 1 to Day 7
  2. Maximum Observed Concentration (Cmax) of DivarasibTime frame: Day 1 to Day 7
  3. Area Under the Concentration-time Curve from Hour 0 to the last measurable concentration (AUC0-t) of DivarasibTime frame: Day 1 to Day 7
  4. Area Under the Concentration-time Curve Extrapolated to Infinity (AUC0-inf) of DivarasibTime frame: Day 1 to Day 7

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Clinical Pharmacology of Miami, Inc.

    Miami, Florida

  • Panax Clinical Research, LLC

    Miami Lakes, Florida

  • Orlando Clinical Research Center

    Orlando, Florida

  • American Research Corporation Inc.

    San Antonio, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.